Format
Sort by
Items per page

Send to

Choose Destination

Best matches for "Fluoxetine":

Fluoxetine: a case history of its discovery and preclinical development. Perez-Caballero L et al. Expert Opin Drug Discov. (2014)

Neuroplasticity and behavioral effects of fluoxetine after experimental stroke. Sun Y et al. Restor Neurol Neurosci. (2017)

Clinical pharmacokinetics of fluoxetine. Altamura AC et al. Clin Pharmacokinet. (1994)

Search results

Items: 1 to 20 of 13538

1.

Serotonergically dependent antidepressant-like activity on behavior and stress axis responsivity of acacetin.

Xiao WZ, Zhou WH, Ma Q, Cui WG, Mei QY, Zhao X.

Pharmacol Res. 2019 Jun 20:104310. doi: 10.1016/j.phrs.2019.104310. [Epub ahead of print]

PMID:
31229563
2.

Liquid-phase microextraction in 96-well plates - calibration and accurate quantification of pharmaceuticals in human plasma samples.

Ask KS, Lid M, Øiestad EL, Pedersen-Bjergaard S, Gjelstad A.

J Chromatogr A. 2019 Jun 8. pii: S0021-9673(19)30622-3. doi: 10.1016/j.chroma.2019.06.013. [Epub ahead of print]

PMID:
31229251
3.

[Effects of Dacryodes edulis fruit oil on anxiety symptoms and cognitive performance in mice, after prolonged administration].

Miguel LM, Okemy-Andissa N, N'jilo D, Mokondjimobe E, Moukassa D, Longo-Mbenza B, Abena AA.

Encephale. 2019 Jun 19. pii: S0013-7006(19)30183-6. doi: 10.1016/j.encep.2019.05.003. [Epub ahead of print] French.

PMID:
31229243
4.

Fluoxetine-related mania in an adolescent girl diagnosed with selective mutism: A case report.

Akaltun İ, Ayaydin H.

Asia Pac Psychiatry. 2019 Jun 20:e12367. doi: 10.1111/appy.12367. [Epub ahead of print] No abstract available.

PMID:
31222962
5.

Antidepressant-like activity of hyperforin and changes in BDNF and zinc levels in mice exposed to chronic unpredictable mild stress.

Szewczyk B, Pochwat B, Muszyńska B, Opoka W, Krakowska A, Rafało-Ulińska A, Friedland K, Nowak G.

Behav Brain Res. 2019 Jun 17:112045. doi: 10.1016/j.bbr.2019.112045. [Epub ahead of print]

PMID:
31220487
6.

Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.

Cambron M, Mostert J, D'Hooghe M, Nagels G, Willekens B, Debruyne J, Algoed L, Verhagen W, Hupperts R, Heersema D, De Keyser J; FLUOX-PMS Study Group.

Mult Scler. 2019 Jun 20:1352458519843051. doi: 10.1177/1352458519843051. [Epub ahead of print]

PMID:
31218911
7.

Quality of Life Assessment in Antidepressant Treatment of Patients with Depression and/or Anxiety Disorder.

Dzevlan A, Redzepagic R, Hadzisalihovic M, Curevac A, Masic E, Alisahovic-Gelo E, Merdzanovic E, Hadzimuratovic A.

Mater Sociomed. 2019 Mar;31(1):14-18. doi: 10.5455/msm.2019.31.14-18.

8.

Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?

Vittengl JR, Clark LA, Thase ME, Jarrett RB.

Behav Ther. 2019 Jul;50(4):765-777. doi: 10.1016/j.beth.2018.11.007. Epub 2018 Dec 8.

PMID:
31208686
9.

Fluoxetine and Risk of Bleeding in Patients Aged 60 Years and Older Using the Korea Adverse Event Reporting System Database: A Case/Noncase Study.

Kim S, Ko YJ, Park K, Yang BR, Kim MS, Park BJ.

J Clin Psychopharmacol. 2019 Jun 14. doi: 10.1097/JCP.0000000000001059. [Epub ahead of print]

PMID:
31206390
10.

Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy.

Amsterdam JD, Kim TT.

J Clin Psychopharmacol. 2019 Jun 11. doi: 10.1097/JCP.0000000000001049. [Epub ahead of print]

PMID:
31205190
11.

Lithium Potentiated, Pyridoxine Abolished and Fluoxetine Attenuated the Anxiolytic Effect of Diazepam in Mice.

Walia V, Garg C, Garg M.

Brain Res Bull. 2019 Jun 12. pii: S0361-9230(18)30883-9. doi: 10.1016/j.brainresbull.2019.06.008. [Epub ahead of print]

PMID:
31201833
12.

4,4'-Dichlorodiphenyl diselenide reverses a depressive-like phenotype, modulates prefrontal cortical oxidative stress and dysregulated glutamatergic neurotransmission induced by subchronic dexamethasone exposure to mice.

Heck SO, Zborowski VA, Quines CB, Nogueira CW.

J Psychiatr Res. 2019 Jun 4;116:61-68. doi: 10.1016/j.jpsychires.2019.05.027. [Epub ahead of print]

PMID:
31200328
13.

Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice.

Kawai H, Iwadate R, Ishibashi T, Kudo N, Kawashima Y, Mitsumoto A.

Chronobiol Int. 2019 Jun 14:1-14. doi: 10.1080/07420528.2019.1625360. [Epub ahead of print]

PMID:
31198056
14.

Efficacy of fluoxetine for anorexia nervosa caused by chemotherapy in patients with cholangiocarcinoma.

Guo LQ, Sun HW, Zhang CY, Feng Y, Teng XL, Qu YK.

Medicine (Baltimore). 2019 Jun;98(24):e15945. doi: 10.1097/MD.0000000000015945.

15.

A new restricted access molecularly imprinted fiber for direct solid phase microextraction of benzodiazepines from plasma samples.

Abrão LCC, Figueiredo EC.

Analyst. 2019 Jun 13. doi: 10.1039/c9an00444k. [Epub ahead of print]

PMID:
31192335
16.

Fluoxetine selectively induces p53-independent apoptosis in human colorectal cancer cells.

Marcinkute M, Afshinjavid S, Fatokun AA, Javid FA.

Eur J Pharmacol. 2019 Jun 7;857:172441. doi: 10.1016/j.ejphar.2019.172441. [Epub ahead of print]

PMID:
31181210
17.

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.

Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G.

Lancet Psychiatry. 2019 Jul;6(7):601-609. doi: 10.1016/S2215-0366(19)30217-2. Epub 2019 Jun 6.

18.

Contribution of serotonergic and nitrergic pathways, as well as monoamine oxidase-a and Na+, K+-ATPase enzymes in antidepressant-like action of ((4-tert-butylcyclohexylidene) methyl) (4-methoxystyryl) sulfide (BMMS).

de Oliveira RL, Voss GT, Paltian JJ, Pinz MP, Torres MLCP, Moreira MP, Dilelio MC, Silveira CC, Wilhelm EA, Luchese C.

Metab Brain Dis. 2019 Jun 8. doi: 10.1007/s11011-019-00436-x. [Epub ahead of print]

PMID:
31177357
19.

Baicalin regulates depression behavior in mice exposed to chronic mild stress via the Rac/LIMK/cofilin pathway.

Lu Y, Sun G, Yang F, Guan Z, Zhang Z, Zhao J, Liu Y, Chu L, Pei L.

Biomed Pharmacother. 2019 Aug;116:109054. doi: 10.1016/j.biopha.2019.109054. Epub 2019 Jun 5.

20.

Methyl-CpG binding protein 2 functional alterations provide vulnerability to develop behavioral and molecular features of post-traumatic stress disorder in male mice.

Cosentino L, Vigli D, Medici V, Flor H, Lucarelli M, Fuso A, De Filippis B.

Neuropharmacology. 2019 Jun 6:107664. doi: 10.1016/j.neuropharm.2019.06.003. [Epub ahead of print]

PMID:
31175878

Supplemental Content

Loading ...
Support Center